Innoviva (INVA) announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica for the commercialization of Zevtera, an advanced-generation cephalosporin ...
Current guidelines recommend that children with acute pyelonephritis are initially treated with a parenteral third-generation cephalosporin such as ceftriaxone, and then oral antibiotics.
The intravenously-administered cephalosporin drug met its objectives in the ERADICATE study in adults with bacterial bloodstream infections caused by Staphylococcus aureus (SAB), setting up an FDA ...
FDC informed that the drug maker has received final approval from United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Cefixime 400 mg tablets.
Basilea enters agreement with Innoviva Specialty Therapeutics for commercialization of antibiotic Zevtera in US: Allschwil, Switzerland Tuesday, December 17, 2024, 15:00 Hrs [IST] ...